Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
Sorel GolandIgor VolodarskyYacov FabricantShay LivschitzSagi TshoriValeri CuciucLiaz ZilbermanIrena FugenfirovValeri MeledinSara ShimoniSagie JosfbergJacob GeorgePublished in: PloS one (2021)
In our study, a meaningful percentage of patients with unexplained LV dysfunction had a co-existing ATTR-CA indicating that the clinical heterogeneity of ATTR-CA is much broader than previously thought.